Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

• Status: Completed
• Trial end date: 2004-03-22
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in Europe. The aim of this trial is to evaluate the acceptance of the new liquid growth hormone formulation, somatropin, in children with growth hormone deficiency.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Growth failure due to growth hormone insufficiency (GHD)

• Turner syndrome: established diagnosis according to sex chromosome analysis, or

• Growth retardation in children with chronic renal disorders

Exclusion Criteria:

• Pregnancy

• Breast feeding women

• Suspected or know allergy to trial product

• Participating in any other trial involving other investigational products within the last 3 months

• Previous participation in the trial

• Other daily injection therapy (non-growth hormone, e.g insulin-therapy)